ValuEngine downgraded shares of Safeguard Scientifics, Inc. (NYSE:SFE) from a hold rating to a sell rating in a research note issued to investors on Tuesday.

Several other research firms also recently commented on SFE. Zacks Investment Research upgraded shares of Safeguard Scientifics from a hold rating to a buy rating and set a $16.00 target price on the stock in a research report on Thursday, November 2nd. BidaskClub downgraded shares of Safeguard Scientifics from a buy rating to a hold rating in a research report on Tuesday, July 25th.

Safeguard Scientifics (SFE) traded up $0.40 during trading hours on Tuesday, reaching $12.60. 52,700 shares of the company traded hands, compared to its average volume of 62,794. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.03 and a current ratio of 1.03. Safeguard Scientifics has a twelve month low of $10.65 and a twelve month high of $14.40.

Safeguard Scientifics (NYSE:SFE) last posted its earnings results on Thursday, October 26th. The asset manager reported ($0.91) EPS for the quarter, topping the consensus estimate of ($1.11) by $0.20. During the same quarter last year, the company earned ($1.18) EPS. analysts expect that Safeguard Scientifics will post -4.47 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally posted by Watch List News and is the property of of Watch List News. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The correct version of this piece of content can be read at https://www.watchlistnews.com/valuengine-lowers-safeguard-scientifics-inc-sfe-to-sell/1710190.html.

Hedge funds and other institutional investors have recently modified their holdings of the company. Neuberger Berman Group LLC acquired a new position in shares of Safeguard Scientifics in the 3rd quarter worth approximately $136,000. American International Group Inc. lifted its position in shares of Safeguard Scientifics by 7.2% in the 1st quarter. American International Group Inc. now owns 12,407 shares of the asset manager’s stock worth $158,000 after purchasing an additional 833 shares during the period. KBC Group NV lifted its position in shares of Safeguard Scientifics by 41.3% in the 2nd quarter. KBC Group NV now owns 13,351 shares of the asset manager’s stock worth $159,000 after purchasing an additional 3,904 shares during the period. Nationwide Fund Advisors lifted its position in shares of Safeguard Scientifics by 7.6% in the 2nd quarter. Nationwide Fund Advisors now owns 14,195 shares of the asset manager’s stock worth $169,000 after purchasing an additional 1,006 shares during the period. Finally, Alliancebernstein L.P. lifted its position in shares of Safeguard Scientifics by 27.4% in the 2nd quarter. Alliancebernstein L.P. now owns 14,430 shares of the asset manager’s stock worth $172,000 after purchasing an additional 3,100 shares during the period. Hedge funds and other institutional investors own 77.91% of the company’s stock.

Safeguard Scientifics Company Profile

Safeguard Scientifics, Inc is engaged in providing capital to technology companies within the fields of healthcare, financial services and digital media. The Company holds interest in companies, which it refers to as partner companies. As of December 31, 2016, the Company held interests in 29 non-consolidated partner companies.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Safeguard Scientifics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.